// App-Quantinova.ai

15636 : Effect of COVID-19 Public Health Measures on Activity and Quality of Life in Patients With Pulmonary Arterial Hypertension

Researchers

Presenter

  • Jennifer T Middleton

Principal Investigators

  • Shiran Konganige

  • Payman Dahaghin

  • Hamza Zafar

  • Ashwin Reddy

  • Claire Martin

  • A.A.R Thompson

  • Andy J Swift

  • Paul Morris

  • Robin Condliffe

  • Nicholas W Morrell

  • David G Kiely

  • Mark Toshner

  • Alex M ROTHMAN

Medical Centers

  • Sheffield Pulmonary Vascular Disease Unit, Sheffield Teaching Hospitals NHS Foundation Trust, Royal Hallamshire Hospital, Sheffield, United Kingdom

  • Med school, Univ of Sheffield, Sheffield, United Kingdom

  • Pulmonary Vascular Disease Unit, Univ of Sheffield, Sheffield, United Kingdom

  • NHS Foundation Trust, Royal Papworth Hosp, Cambridge, United Kingdom

  • Univ of Sheffield, Sheffield

  • UNIVERSITY OF CAMBRIDGE, Cambridge

  • Sheffield Teaching Hospitals, Sheffiled, UK

  • Univ of Cambridge UK, Cambridge

  • UNIVERSITY OF SHEFFIELD, Sheffield

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Pulmonary arterial hypertension

  • Depression

  • Coronavirus disease

  • Anxiety

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved